Description (Peptide Therapy for Sexual Function, Libido Enhancement, and Arousal Response) Advanced Peptide Solution for Sexual Wellness and Desire Regulation PT-141 , also known by its generic name Bremelanotide , is a melanocortin receptor agonist developed to address hypoactive sexual desire disorder (HSDD) and sexual arousal dysfunction in both men and women
Food and Drug Administration also warns the drugs may increase the risk of thyroid cancer, acute pancreatitis, gallbladder disease, low blood sugar, kidney injury, damage to the eye's retina and suicidal thinking or behavior, although the risks of serious side effects are small
Every batch is independently tested by third-party laboratories for purity and identity
GLP-1R + neurons in the hindbrain also suppress hepatic glucose production
Caution Keep out of reach of children